phase readout
saveNCT06959225: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Hidradenitis Suppurativa
view source ↗
comments(0)
5-min edit window · permanent after that